| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Evans M | |
| Boyes WK | |||
| Bushnell PJ | |||
| Crofton KM | |||
| Simmons JE | |||
| P2860 | cites work | Acute effects of trichloroethylene on blood concentrations and performance decrements in rats and their relevance to humans. | Q33583911 |
| Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment | Q33916719 | ||
| Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics | Q35134362 | ||
| Rat and human sensory evoked potentials and the predictability of human neurotoxicity from rat data | Q36715766 | ||
| The ototoxicity of trichloroethylene: extrapolation and relevance of high-concentration, short-duration animal exposure data | Q36878463 | ||
| CNS depressant effects of volatile organic solvents | Q37181585 | ||
| A critical review of time-weighted average as an index of exposure and dose, and of its key elements | Q39862021 | ||
| Impact of occupational hearing loss on the lives of workers | Q40956350 | ||
| Distribution of cardiac output during diurnal changes of activity in rats | Q41171768 | ||
| Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil | Q41431665 | ||
| Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats | Q45184528 | ||
| Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues | Q47173676 | ||
| Physiologically-based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites | Q47843571 | ||
| Effects of medial prefrontal or anterior cingulate cortex lesions on responding for cocaine under fixed-ratio and second-order schedules of reinforcement in rats. | Q48560215 | ||
| Solvent-induced ototoxicity in rats: an atypical selective mid-frequency hearing deficit. | Q50523199 | ||
| Mid-frequency hearing loss in rats following inhalation exposure to trichloroethylene: evidence from reflex modification audiometry. | Q50527387 | ||
| Mid-frequency hearing loss and reduction of acoustic startle responding in rats following trichloroethylene exposure. | Q50527391 | ||
| Sensory-evoked potentials in rats chronically exposed to trichloroethylene: predominant auditory dysfunction. | Q50546195 | ||
| A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. | Q50852848 | ||
| Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice. | Q51476962 | ||
| Concentration-time relationships for the effects of inhaled trichloroethylene on signal detection behavior in rats. | Q51547577 | ||
| Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. | Q51738673 | ||
| Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. | Q51751604 | ||
| Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. | Q51789218 | ||
| A dosimetric analysis of behavioral effects of acute toluene exposure in rats and humans. | Q52185195 | ||
| Effects of single exposure to toluene on operant behavior and brain toluene levels in rats. | Q52277712 | ||
| A comparison of the acute neuroactive effects of dichloromethane, 1,3-dichloropropane, and 1,2-dichlorobenzene on rat flash evoked potentials (FEPs). | Q52552267 | ||
| A new method for determining allowable daily intakes. | Q52687390 | ||
| A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. | Q52695093 | ||
| Adjusting Exposure Limits for Long and Short Exposure Periods Using A Physiological Pharmacokinetic Model | Q57383628 | ||
| Reference dose (RfD): description and use in health risk assessments | Q68026014 | ||
| Physiologically based pharmacokinetic estimated metabolic constants and hepatotoxicity of carbon tetrachloride after methanol pretreatment in rats | Q71718095 | ||
| Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats | Q72171241 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| neurotoxicity | Q3338704 | ||
| hydrocarbon | Q43648 | ||
| impact of the environment | Q26897695 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 317-322 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario | |
| P478 | volume | 108 Suppl 2 |
| Q46981486 | An example of model structure differences using sensitivity analyses in physiologically based pharmacokinetic models of trichloroethylene in humans |
| Q46786767 | Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane. |
| Q37201545 | Approaches for applications of physiologically based pharmacokinetic models in risk assessment |
| Q58402056 | Assessing the impact of the duration and intensity of inhalation exposure on the magnitude of the variability of internal dose metrics in children and adults |
| Q51407706 | Behavioral components of tolerance to repeated inhalation of trichloroethylene (TCE) in rats. |
| Q43855521 | Characterizing tolerance to trichloroethylene (TCE): effects of repeated inhalation of TCE on performance of a signal detection task in rats |
| Q42730136 | Chronic exposure to trichloroethylene affects neuronal plasticity in rat hippocampal slices |
| Q43239567 | Development of an inhalation physiologically based pharmacokinetic (PBPK) model for 2,2, 4-trimethylpentane (TMP) in male Long-Evans rats using gas uptake experiments |
| Q46603013 | Duration adjustment of acute exposure guideline level values for trichloroethylene using a physiologically-based pharmacokinetic model |
| Q33916719 | Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment |
| Q35039295 | Key scientific issues in the health risk assessment of trichloroethylene |
| Q46601305 | Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose |
| Q33916692 | Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene |
| Q43336435 | Recycled water: potential health risks from volatile organic compounds and use of 1,4-dichlorobenzene as treatment performance indicator. |
| Q35802386 | The Acute Exposure Guideline Level (AEGL) program: applications of physiologically based pharmacokinetic modeling |
| Q46952375 | The role of physical activity and feeding schedule on the kinetics of inhaled and oral toluene in rats |
| Q24671489 | Trichloroethylene health risks--state of the science |
Search more.